Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cyclodextrin refers to a group of cyclic oligosaccharides composed of 6 (α-cyclodextrin), 7 (β-cyclodextrin), or 8 (γ-cyclodextrin) D-glucose units linked by α-1,4 glycosidic bonds, forming a truncated cone shape. The exterior is hydrophilic due to hydroxyl groups, while the interior is hydrophobic, allowing cyclodextrins to form inclusion complexes with hydrophobic molecules in aqueous solutions. Cyclodextrins are not biological receptors or enzymes, but are highly valued in the pharmaceutical, food, and chemical industries for their ability to improve the solubility, stability, and delivery of otherwise poorly soluble molecules. Various derivatives (e.g., hydroxypropyl-β-cyclodextrin) are used to modulate solubility and inclusion properties further. Cyclodextrins are considered nontoxic at pharmaceutical doses but may cause renal or auditory toxicity at high doses, especially with β-cyclodextrin.
Enhance solubility and stability of guest molecules via inclusion complex formation within the hydrophobic central cavity; act as molecular carriers
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cyclodextrin (CD).